4151.T Kyowa Hakko Kirin Co., Ltd.
¥2,209 0.00%
Asia · Pharmaceuticals
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
0.00%
YTD
-6.40%
P/E
—
P/B
—
ROE
—
Div yield
—
Beta
0.01
Market cap
—
RSI (14)
35
Next earnings
—
Previous session
close of Oct 8, 2026 · EOD, no live order bookOpen
¥2,240
Close
¥2,209
VWAP (n/a)
—
Day high
¥2,247
Day low
¥2,201
Volume
2.1M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Kyowa Kirin, Knight agree Latin American distribution deal for mogamulizumab
Yahoo Finance · Sep 30
Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® (mogamulizumab) for Cutaneous T-Cell Lymphoma (CTCL) Patients Across Latin America
Yahoo Finance · Sep 29
Is Kyowa Kirin (TSE:4151) A Bargain Following Its Share Price Pullback?
Yahoo Finance · Sep 25
Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans
Yahoo Finance · Aug 31
Is Cognizant (CTSH) Quietly Redefining Its Automation Edge With Kyowa Kirin’s AI R&D Deal?
Yahoo Finance · Aug 26
Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)
Yahoo Finance · Sep 29
Headlines via Yahoo Finance · links open the source · not an endorsement.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell 4151.T. Try it in the Lab to size a position and see the risk.